Aldosterone induces cardiotrophin-1 expression in HL-1 adult cardiomyocytes

Endocrinology

Volumn 149, Issue 10, 2008, Pages 4970-4978

  López Andrés, Natalia ^a   Iñigo, Carmen ^a   Gallego, Idoia ^a   Díez, Javier ^a,b   Fortuño, María Antonia ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALDOSTERONE; CARDIOTROPHIN 1; DACTINOMYCIN; MESSENGER RNA; MIFEPRISTONE; PHALLOIDIN; PROTEIN C FOS; SPIRONOLACTONE;

ARTICLE; CELL SIZE; CONTROLLED STUDY; HEART MUSCLE CELL; IMAGE ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGE FACTORS; ALDOSTERONE; ANIMALS; CARDIOMEGALY; CELL LINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MICE; MYOCYTES, CARDIAC; RNA, MESSENGER; UP-REGULATION;

EID: 53249125773     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0120     Document Type: Article

References (49)

1. Marney AM, Brown NJ 2007 Aldosterone and end-organ damage. Clin Sci (Lond) 113:267-278
2. Matsumura K, Fujii K, Oniki H, Oka M, Iida M 2006 Role of aldosterone in left ventricular hypertrophy in hypertension. Am J Hypertens 19:13-18
3. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248
4. Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P, Pessina AC 1996 Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 27:1039-1045
5. Rossi GP, Di Bello V, Ganzaroli C, Sacchetto A, Cesari M, Bertini A, Giorgi D, Scognamiglio R, Mariani M, Pessina AC 2002 Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 40:23-27
6. Nakahara T, Takata Y, Hirayama Y, Asano K, Adachi H, Shiokawa G, Sumi T, Ogawa T, Yamashina A 2007 Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide. Circ J 71:716-721
7. Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH 2005 Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 90:5070-5076
8. Beggah AT, Escoubet B, Puttini S, Cailmail S, Delage V, Ouvrard-Pascaud A, Bocchi B, Peuchmaur M, Delcayre C, Farman N, Jaisser F 2002 Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes. Proc Natl Acad Sci USA 99:7160-7165
9. Tsukamoto O, Minamino T, Sanada S, Okada K, Hirata A, Fujita M, Shintani Y, Yulin L, Asano Y, Takashima S, Yamasaki S, Tomoike H, Hori M, Kitakaze M 2006 The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats. Cardiovasc Drugs Ther 20:93-102
10. Qin W, Rudolph AE, Bond BR, Rocha R, Blomme EA, Goellner JJ, Funder JW, McMahon EG 2003 Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res 93:69-76
11. Yoshida K, Kim-Mitsuyama S, Wake R, Izumiya Y, Izumi Y, Yukimura T, Ueda M, Yoshiyama M, Iwao H 2005 Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress. Hypertens Res 28:447-455
12. Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H 2000 Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology 141:1901-1904
13. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh SM, Darbonne WC, Knutzon DS, Yen R, Chien KR, Barker JB, Wi W 1995 Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 92:1142-1146
14. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR 1996 Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 271:9535-9545
15. López N, Díez J, Fortuño MA 2006 Differential hypertrophic effects of cardiotrophin-1 on adult cardiomyocytes from normotensive and spontaneously hypertensive rats. J Mol Cell Cardiol 41:902-913
16. Jin H, Yang R, Keller GA, Ryan A, Ko A, Finkle D, Swanson TA, Li W, Pennica D, Wood WI, Paoni NF 1996 In vivo effects of cardiotrophin-1. Cytokine 8:920-926
17. Ishikawa M, Saito Y, Miyamoto Y, Harada M, Kuwahara K, Ogawa E, Nakagawa O, Hamanaka I, Kajiyama N, Takahashi N, Masuda I, Hashimoto T, Sakai O, Hosoya T, Nakao K 1999 A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J Hypertens 17:807-816
18. Pemberton CJ, Raudsepp SD, Yandle TG, Cameron VA, Richards AM 2005 Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc Res 68:109-117
19. López B, Gonzalez A, Lasarte JJ, Sarobe P, Borras F, Diaz A, Barba J, Tomas L, Lozano E, Serrano M, Varo N, Beloqui O, Fortuño MA, Díez J 2005 Is plasma cardiotrophin-1 a marker of hypertensive heart disease? J Hypertens 23:625-632
20. Gonzalez A, López B, Martín-Raymondi D, Lozano E, Varo N, Barba J, Serrano M, Díez J 2005 Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients. J Hypertens 23:2293-2300
21. Funamoto M, Hishinuma S, Fujio Y, Matsuda Y, Kunisada K, Oh H, Negoro S, Tone E, Kishimoto T, Yamauchi-Takihara K 2000 Isolation and characterization of the murine cardiotrophin-1 gene: expression and norepinephrine-induced transcriptional activation. J Mol Cell Cardiol 32:1275-1284
22. Sano M, Fukuda K, Kodama H, Takahashi T, Kato T, Hakuno D, Sato T, Manabe T, Tahara S, Ogawa S 2000 Autocrine/paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation. Biochem Biophys Res Commun 269:798-802
23. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, Takahashi T, Makino S, Kato T, Ogawa S 2000 Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 275:29717-29723
24. Claycomb WC, Lanson Jr NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo Jr NJ 1998 HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95:2979-2984
25. Sierra A, Gottfried-Blackmore A, Milner TA, McEwen BS, Bulloch K 2008 Steroid hormone receptor expression and function in microglia. Glia 56:659-674
26. Callera GE, Montezano AC, Yogi A, Tostes RC, He Y, Schiffrin EL, Touyz RM 2005 c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats. Hypertension 46:1032-1038
27. Callera GE, Touyz RM, Tostes RC, Yogi A, He Y, Malkinson S, Schiffrin EL 2005 Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension 45:773-779
28. Karmazyn M, Liu Q, Gan XT, Brix BJ, Fliegel L 2003 Aldosterone increases NHE-1 expression and induces NHE-1-dependent hypertrophy in neonatal rat ventricular myocytes. Hypertension 42:1171-1176
29. Okoshi MP, Yan X, Okoshi K, Nakayama M, Schuldt AJ, O'Connell TD, Simpson PC, Lorell BH 2004 Aldosterone directly stimulates cardiac myocyte hypertrophy. J Card Fail 10:511-518
30. Gaeggeler HP, Gonzalez-Rodriguez E, Jaeger NF, Loffing-Cueni D, Norregaard R, Loffing J, Horisberger JD, Rossier BC 2005 Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line. J Am Soc Nephrol 16:878-891
31. Sugiyama T, Yoshimoto T, Tsuchiya K, Gochou N, Hirono Y, Tateno T, Fukai N, Shichiri M, Hirata Y 2005 Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells. Endocrinology 146:3900-3906
32. Gauer S, Segitz V, Goppelt-Struebe M 2007 Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor. Nephrol Dial Transplant 22:3154-3159
33. Fuller PJ, Lim-Tio SS, Brennan FE 2000 Specificity in mineralocorticoid versus glucocorticoid action. Kidney Int 57:1256-1264
34. Benitah JP, Vassort G 1999 Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes. Circ Res 85:1139-1145
35. Whitehurst Jr RM, Zhang M, Bhattacharjee A, Li M 1999 Dexamethasone-induced hypertrophy in rat neonatal cardiac myocytes involves an elevated L-type Ca(2+)current. J Mol Cell Cardiol 31:1551-1558
36. Muller O, Pradervand S, Berger S, Centeno G, Milet A, Nicod P, Pedrazzini T, Tronche F, Schutz G, Chien K, Rossier BC, Firsov D 2007 Identification of corticosteroid-regulated genes in cardiomyocytes by serial analysis of gene expression. Genomics 89:370-377
37. Funder JW 2006 Mineralocorticoid receptors and cardiovascular damage: it's not just aldosterone. Hypertension 47:634-635
38. Funder JW 2007 Mineralocorticoid receptor activation and oxidative stress. Hypertension 50:840-841
39. Rickard AJ, Funder JW, Morgan J, Fuller PJ, Young MJ 2007 Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration? Endocrinology 148:4829-4835
40. Funder JW 2006 Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects. Endocrinology 147:5564-5567
41. Grossmann C, Gekle M 2007 Non-classical actions of the mineralocorticoid receptor: misuse of EGF receptors? Mol Cell Endocrinol 277:6-12
42. Hammes SR 2003 The further redefining of steroid-mediated signaling. Proc Natl Acad Sci USA 100:2168-2170
43. Le Moellic C, Ouvrard-Pascaud A, Capurro C, Cluzeaud F, Fay M, Jaisser F, Farman N, Blot-Chabaud M 2004 Early nongenomic events in aldosterone action in renal collecting duct cells: PKCα activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response. J Am Soc Nephrol 15:1145-1160
44. Grossmann C, Benesic A, Krug AW, Freudinger R, Mildenberger S, Gassner B, Gekle M 2005 Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol Endocrinol 19:1697-1710
45. Perrier R, Richard S, Sainte-Marie Y, Rossier BC, Jaisser F, Hummler E, Benitah JP 2005 A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice. J Physiol 569:153-162
46. Lee YS, Kim JA, Kim KL, Jang HS, Kim JM, Lee JY, Shin IS, Lee JS, Suh W, Choi JH, Jeon ES, Byun J, Kim DK 2004 Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes. J Korean Med Sci 19:805-811
47. Talwar S, Squire IB, Downie PF, O'Brien RJ, Davies JE, Ng LL 2000 Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clin Sci (Colch) 99:83-88
48. Zolk O, Ng LL, O'Brien RJ, Weyand M, Eschenhagen T 2002 Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance. Circulation 106:1442-1446
49. Gonzalez A, Ravassa S, Loperena I, Lopez B, Beaumont J, Querejeta R, Larman M, Diez J 2007 Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. J Hypertens 25:2148-2157